Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It primarily affects males, with symptoms typically appearing in early childhood. DMD is caused by a mutation in the dystrophin gene, which is responsible for producing a protein essential for muscle function.
The most noticeable symptoms of DMD include difficulty in walking, frequent falls, and a waddling gait. As the disease progresses, individuals may experience muscle weakness in the arms, legs, and trunk, leading to limited mobility. DMD can also affect the muscles involved in breathing and the heart, potentially causing respiratory and cardiac complications.
Early diagnosis and intervention are crucial in managing DMD. While there is currently no cure, various treatments and therapies can help slow down the progression of the disease and improve quality of life. These may include physical therapy, medications, assistive devices, and respiratory support.
It is important for individuals with DMD to receive comprehensive care from a multidisciplinary team of healthcare professionals, including neurologists, physical therapists, respiratory therapists, and cardiologists. Ongoing research and advancements in gene therapy hold promise for potential future treatments.